{'fraction_non_alphanumeric': 0.04386617100371747, 'fraction_numerical': 0.026765799256505577, 'mean_word_length': 5.37914691943128, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 1, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
bcl‐2 rearrangement detected by pulsed‐field gel electrophoresis (PFGE) in B‐chronic lymphocytic leukemia (CLL) cells

B‐chronic lymphocytic leukemia (CLL) is characterized by an accumulation of long‐lived, resting B cells expressing the Bcl‐2 protein. However, less than 10% of the CLL patients shows bcl‐2 gene rearrangement in blood cells, using traditional Southern blotting analysis. In the present study, rearrangement of thebcl‐2 gene in CLL cells was studied by pulsed‐field gel electrophoresis (PFGE). With this method, large DNA fragments (>50–10,000 kb) could be analyzed. Blood CLL cells from 9 of 9 patients and 2 of 2 CLL cell lines showed rearranged bcl‐2 gene. In comparison, healthy blood B cells and lymphoblastoid cell lines (LCLs) established from normal peripheral blood lymphocytes of the patients showed only germ line configuration. Thus, the possibility of restriction fragment length polymorphisms (RFLPs) in this gene could be excluded. The primary cell involved in CLL might be a progenitor B cell that has accidentally rearranged the bcl‐2gene. As a consequence, such cells express stable amount of Bcl‐2 protein and do not enter apoptosis. During prolonged survival, such cells may acquire secondary changes including chromosomal translocations and mutations. Int. J. Cancer 76:909–912, 1998.© 1998 Wiley‐Liss, Inc.